and genome- sequencing centers have similar in-house projects. Much like the NCI project, the unusual responder pro- gram at the University of Texas, MD Anderson Cancer Center, is beginning by combing through the archives to hunt for outliers of the past. A patient at the clinic who has an unusual response—good or ba